HeartSciences (HSCS) Gross Margin (2021 - 2025)

Name: HeartSciences (HSCS) Gross Margin (2021 - 2025) | Business Quant
Creator: Business Quant

HeartSciences posted quarterly Gross Margin of 58.33% for Q4 2025, down 2.78% on a QoQ basis from 60.0% in Q3 2025.

HeartSciences (HSCS) has 5 years of Gross Margin data on file, last reported at 58.33% in Q4 2025.

For the quarter ending Q4 2025, Gross Margin changed N/A year-over-year to 58.33%; the trailing twelve-month figure through Jan 2026 stood at 57.92% (down 939.0% YoY), and the FY2025 full-year result was 56.78%, down 1052.0% from the prior year.
Gross Margin for Q4 2025 stood at 58.33%, down from 60.0% in the prior quarter.
Across five years, Gross Margin topped out at 69.15% in Q2 2022 and bottomed at 23.09% in Q3 2021.
The 5-year median for Gross Margin is 60.51% (2025), against an average of 56.36%.
The widest annual swing landed in 2022, when Gross Margin soared 1329 bps; it then sank 781 bps in 2023.
A 5-year view of Gross Margin shows it stood at 23.09% in 2021, then surged by 58 bps to 36.38% in 2022, then jumped by 68 bps to 61.03% in 2023, then climbed by 13 bps to 68.97% in 2024, then dropped by 15 bps to 58.33% in 2025.
The last three Gross Margin figures came in at 58.33% (Q4 2025), 60.0% (Q3 2025), and 56.78% (Q2 2025), per Business Quant data.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	56.20%
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	63.29%
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	63.83%
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	69.46%
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	78.01%
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	45.22%
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	62.95%
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	38.53%
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	43.89%
10	HeartSciences	4.56 Mn	1.16 Mn	-	-

Download Data 🔒